Alpha Cognition Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACOG Nasdaq 2836 www.alphacognition.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alpha Cognition Inc.

Alpha Cognition (ACOG) Q2 2026 Earnings Call Transcript - Aug 13th, 2026 8:59 pm
Alpha Cognition Q2 Earnings Call Highlights - Aug 13th, 2026 4:04 pm
Alpha Cognition Inc. (ACOG) Reports Q2 Loss, Tops Revenue Estimates - Aug 13th, 2026 3:15 pm
Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update - Aug 13th, 2026 2:05 pm
Liquidia Corporation (LQDA) Q2 Earnings and Revenues Beat Estimates - Aug 12th, 2026 5:40 am
Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Aug 6th, 2026 8:00 am
Fluence Energy Set to Report Q3 Earnings: What's in Store? - Aug 4th, 2026 11:53 am
Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update - Aug 3rd, 2026 6:30 am
Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Beats Revenue Estimates - Jul 30th, 2026 5:50 am
Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease - Jul 29th, 2026 6:30 am
Alpha Cognition Inc. (ACOG) Surges 8.6%: Is This an Indication of Further Gains? - Jul 28th, 2026 4:55 am
Time to Jump In? Raymond James Is Bullish on These 2 Stocks - Jul 23rd, 2026 11:57 am
Raymond James Starts Alpha Cognition (ACOG) at Outperform - Jul 14th, 2026 12:08 pm
Alpha Cognition (ACOG) Stock Fair Value Moves Lower As Analysts Weigh Zunveyl Persistence - Jul 11th, 2026 4:08 pm
Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit - Jul 10th, 2026 6:30 am
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board - Jun 23rd, 2026 6:30 am
Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer’s Disease - Jun 16th, 2026 6:30 am
We Think Alpha Cognition (NASDAQ:ACOG) Needs To Drive Business Growth Carefully - Jun 13th, 2026 7:52 am
Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease - Jun 9th, 2026 6:00 am